\
&
Contact us
\
&
Contact us
This was 8 months ago
Locationİstanbul, Türkiye
An international matchmaking event will be held in Istanbul as an opportunity to find European and Turkish partners both from the research and industrial communities to apply to upcoming Horizon Europe calls.
The Brokerage will include opportunities to form new partnerships through four parallel workshops on the topics:
A limited number of participants of countries affiliated to the Horizon Europe programme can apply for reimbursement for travel and accommodation expenses (!this is only possibly before 10 March 2025). A full description of the reimbursement procedure is available here: https://lnkd.in/dyWX2YgR
More information on the event, the agenda and registration on the event website. Registration is open until 7 April.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
